AbbVie Reports Second-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
AbbVie (ABBV) Tops Q2 EPS by 15c, Issues Combined Company Guidance
July 31, 2020 7:45 AM EDTAbbVie (NYSE: ABBV) reported Q2 EPS of $2.34, $0.15 better than the analyst estimate of $2.19. Revenue for the quarter came in at $10.43 billion versus the consensus estimate of $10.08 billion.
Full-Year 2020 Outlook:
AbbVie previously issued standalone GAAP diluted EPS guidance for the full-year... More
